Journal of Clinical Epidemiology
Volume 55, Issue 2 , Pages 111-114 , February 2002

Parental cancer as a risk factor for bone cancer: A nation-wide study from Sweden

Received 27 November 2000 ,Revised 18 July 2001 ,Accepted 19 July 2001.

References 

  1. Carnevale A, Lieberman E, Cardenas R. Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma. Arch Med Res. 1997;28:383–386
  2. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, et al  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233–1238
  3. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341:342–352
  4. Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, et al. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop. 1991;270:271–277
  5. Hansen MF. Molecular genetic considerations in osteosarcoma. Clin Orthop. 1991;270:237–246
  6. Moll AC, Imhof SM, Bouter LM, Tan KE. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalm Genet. 1997;18:27–34
  7. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990;348:747–749
  8. Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606–611
  9. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF, Li FP. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res. 1991;51:6094–6097
  10. Bovee JV, Cleton-Jansen AM, Wuyts W, Caethoven G, Taminiau AH, Bakker E, et al. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet. 1999;65:689–698
  11. Wunder JS, Eppert K, Burrow SR, Gogkoz N, Bell RS, Andrulis IL. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene. 1999;18:783–788
  12. Pellin A, Boix-Ferrero J, Carpio D, Lopez-Terrada D, Carda C, Navarro S, et al. Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas. Diagn Mol Pathol. 1997;6:333–341
  13. Hemminki K, Vaittinen P. Familial risks in second primary breast cancer based on a family cancer database. Eur J Cancer. 1999;35:455–458
  14. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol. 1998;15:225–236
  15. Hemminki K, Vaittinen P. Familial cancers in a nationwide family cancer database (age distribution and prevalence). Eur J Cancer. 1999;35:1109–1117
  16. Hemminki K, Vaittinen P, Kyyronen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer. 1998;78:172–175
  17. Hemminki K, Vaittinen P. Familial breast cancer in the family-cancer database. Int J Cancer. 1998;77:386–391
  18. Hemminki K, Kyyronen P, Vaittinen P. Parental age as a risk factor of childhood leukemia and brain cancer in offspring. Epidemiology. 1999;10:271–275
  19. Hemminki K, Vaittinen P. Familial risks in in situ cancers from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev. 1998;7:865–868
  20. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ. 1994;128:1–302
  21. Gelberg KH, Fitzgerald EF, Hwang S, Dubrow R. Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol. 1997;26:272–278
  22. Hum L, Kreiger N, Finkelstein MM. The relationship between parental occupation and bone cancer risk in offspring. Int J Epidemiol. 1998;27:766–771
  23. Buckley JD, Pendergrass TW, Buckley CM, Pritchard DJ, Nesbit ME, Provisor AJ, et al. Epidemiology of osteosarcoma and Ewing's sarcoma in childhood (a study of 305 cases by the Children's Cancer Group). Cancer. 1998;83:1440–1448
  24. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, et al  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54:1298–1304
  25. Fearon ER. Human cancer syndromes (clues to the origin and nature of cancer). Science. 1997;278:1043–1050
  26. Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome—a molecular and clinical review. Br J Cancer. 1997;76:1–14
  27. Malkin D. The Fi-Fraumeni syndrome. In:  Vogelstein B,  Kinzler KW editor. The gentic basis of human cancer. New York: McGraw-Hill; 1998;p. 393–407
  28. Yaw KM. Pediatric bone tumors. Semin Surg Oncol. 1999;16:173–183
  29. Hartley AL, Birch JM, Blair V, Teare MD, Marsden HB, Harris M. Cancer incidence in the families of children with Ewing's tumor. J Natl Cancer Inst. 1991;83:955–956
  30. Novakovic B, Goldstein AM, Wexler LH, Tucker MA. Increased risk of neuroectodermal tumors and stomach cancer in relatives of patients with Ewing's sarcoma family of tumors. J Natl Cancer Inst. 1994;86:1702–1706

PII: S0895-4356(01)00435-8

Journal of Clinical Epidemiology
Volume 55, Issue 2 , Pages 111-114 , February 2002

Article Tools

* Image Usage & Resolution